• Study on the Safety and Effectiveness of Telisotuzumab Vedotin for Patients with Previously Treated c-Met Positive Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Greece Ireland Italy +2
  • Study on Lutetium (177Lu) Vipivotide Tetraxetan and Androgen Receptor Inhibitors for Patients with Castration-Resistant Prostate Cancer

    Not recruiting

    2 1 1 1
    Czechia France Germany Italy The Netherlands Poland +1
  • Study on Dulaglutide for Preventing Diabetes in Patients with Metabolic Syndrome Awaiting Kidney Transplantation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study on the Safety and Effectiveness of Pembrolizumab, Vibostolimab, and Lenvatinib for Patients with PD-1 Refractory Melanoma

    Not recruiting

    1 1 1 1
    France Italy
  • Study on Dulaglutide for Preventing Diabetes in New Kidney Transplant Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study Comparing Tisotumab Vedotin with Chemotherapy for Patients with Recurrent or Metastatic Cervical Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Czechia Finland France Germany +7
  • Study on Vilobelimab and Drug Combination for Treating Ulcerative Pyoderma Gangrenosum in Adults

    Not recruiting

    3 1 1
    Investigated Diseases:
    Belgium France Germany Hungary Italy The Netherlands +2
  • Study of Trastuzumab Deruxtecan for Patients with Unresectable or Metastatic HER2-low or HER2 IHC0 Breast Cancer

    Not recruiting

    2 1 1
    Investigated Drugs:
    Belgium Ireland Italy The Netherlands Portugal Spain
  • Study on the Effectiveness of Deucravacitinib for Patients with Lichen Planus

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study on the Effects of Vitamin D3 in Patients with Periodontitis and Vitamin D Deficiency

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium

powered by